daily oral glp-1 receptor agonist orforglipron for adults with obesity Late breaking at #ADA2023: In this 36-week, randomized trial, was associated clinically significant weight reduction, with efficacy and safety similar to those of injectable agonists. https://t.co/lNjqjAF5oc 🚨 Move over Ozempic—there’s a
Pay in 4 interest-free payments of $5.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8






















